BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 6506358)

  • 1. Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.
    Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
    Cancer Immunol Immunother; 1986; 21(1):1-5. PubMed ID: 3632914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
    Flamm J; Burkert S
    Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
    Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
    Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of host immunocompetence in urologic cancer patients.
    Catalona WJ; Smolev JK; Harty JI
    J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNCB reactivity and prognosis in 419 patients with malignant melanoma.
    Camacho ES; Pinsky CM; Braun DW; Golbey RB; Fortner JG; Wanebo HJ; Oettgen HF
    Cancer; 1981 May; 47(10):2446-50. PubMed ID: 7272900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of the DNCB test in bladder cancer. Pretreatment evaluation of immune function and 5-year follow-up of patients with urinary bladder cancer.
    Flamm J; Sagaster P; Micksche M
    Urol Int; 1984; 39(5):257-63. PubMed ID: 6506358
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.